GAITHERSBURG, Md.--Gene Logic here announced that it was issued a US patent for an enzyme-based genomics technology, "differential display," in which restriction enzymes reveal differences in gene expression among various tissue samples. Gene Logic said that methods based on the approach covered by the patent are more suitable for industrial-scale operations than a differential display method that doesn't require restriction enzymes.